قرحات الساق, دراسة وبائية سبيية وعلاجية
Abstract
- قرحة الساق مرض شائع ومنتشر عالمياً ، يصيب كلا الجنسين وكل الأعمار ، ويزداد حدوثه مع تقدم العمر.
- إن قرحة الساق حالة مرضية شديدة الارتباط مع الاضطرابات الوعائية ، وإن أكثر اختلاطاتها هو الإنتان والتهاب الجلد بالتماس.
- يعتمد علاج قرحة الساق الأساسي على التشخيص الدقيق لسبب القرحة وعلاجه ، ثم علاج الاختلاطات وخاصة الإنتان الثانوي ، ثم المساعدة على الترمم باستخدام مستحضرات مختلفة ، ونادراً ما تحتاج قرحة الساق إلى تداخل جراحي.
- تضمن البحث 35 مريضاً مصاباً بقرحة ساق من المراجعين للعيادة الجلدية في مشفى الأسد الجامعي في اللاذقية خلال فترة الدراسة الممتدة من شهر شباط 2004 حتى شهر حزيران 2005.
- كانت نسبة انتشار قرحة الساق بين المراجعين للعيادة الجلدية ( 0.32%) ، وبلغ عدد المرضى الذكور ( 18) مريضاً وعدد الإناث ( 7) ،وكان العمر الوسطي للمرضى ( 48 سنة ) وأكثر الفئات العمرية إصابة بهذا المرض هي
( 61-70 سنة ) و( 31-40 ) .
- كان أكثر أسباب قرحة الساق القصور الوريدي المزمن وبنسبة ( 25.71%) ثم القصور الشرياني بنسبة ( 22.86%).
- كان أكثر الاختلاطات شيوعاً هو الإنتان الثانوي والتهاب الجلد بالتماس.
- شملت الدراسة العلاجية بالمستحضرات المساعدة على الترميم ( 22) مريض وكانت أفضل النتائج مع استخدام Mebo® ، وSilver Leaf® بنسبة شفاء ( 100%) وبفترة وسطية للشفاء مقدارها ( 8) أسابيع.
Leg ulcer is a common disease world-wide. It involves both sexes, all ages, and its incidence increases proportionally with age.
Leg ulcer is severely related to vascular disorders, and its most common complications are infection and contact dermatitis.
The essential treatment of leg ulcer depends on the accurate diagnosis of the cause of leg ulcer, then treating the reason and the complications, especially secondary infections, followed by using a variety of products in order to urge the renovation process; leg ulcers rarely need surgical approachment.
The research included 35 patients having leg ulcer who had attended the dermatological and veneral clinic at Assad Hospital in Lattakia during the research period starting February 2004 till June 2005.
The rate of leg ulcers amongst patients attending the dermatological clinic was 0.32%, of whom there were 18 males and 7 females. The median age of patients was 48 years, and the most involved age group was (61-70) and ( 31-40).
The most common cause of leg ulcer was chronic venous insufficiency (rate of 25.71% ), in second place comes arterial insufficiency ( rate of 22.86%).
The most common complication was secondary infection and contact dermatitis.
The therapeutical study of the renovating products included 22 patients. Best results were found when Mebo® and (silver – leaf ®) where used accomplishing a healing rate of 100% in 8 weeks as a median interval for recovery.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.